CVD Registry: Registry of Cardiovascular Disease Patients

Sponsor
Maccabi Healthcare Services, Israel (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT01759225
Collaborator
(none)
110,000
1

Study Details

Study Description

Brief Summary

A computerized registry of cardiovascular disease patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify cardiovascular disease patients and to follow the courses of their illnesses and risk factors.

Detailed Description

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.

The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
110000 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Computerized Registry of Cardiovascular Disease Patients
Study Start Date :
Jan 1, 1998
Anticipated Primary Completion Date :
Dec 1, 2100

Arms and Interventions

Arm Intervention/Treatment
Cardiovascular Disease Patients

Outcome Measures

Primary Outcome Measures

  1. Number of Patients with Cardiovascular disease [Up to 100 years]

Secondary Outcome Measures

  1. prevalence rates of CVD [up to 100 years]

  2. Major Adverse Cardiac Events [up to 100 years]

  3. Number of LDL Tests performed reaching target LDL [up to 100 years]

  4. Proportion of dyslipidemia patients treated with Statins [up to 100 years]

Other Outcome Measures

  1. hospitalization days due to CVD [up to 100 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical Diagnosis of the following:

Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA,patients with first AMI diagnosis from community physicians if they were hospitalized for lasting at least 3 days during a 30-day period prior to diagnosis.

  • Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes
Exclusion Criteria:
  • patients who were diagnosed as suffering from CHD by primary physician or general hospitals prior to 2000 with no further indication

  • Patients whose primary physician reported that the patient is CHD-free providing adequate medical records

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maccabi Healthcare Services Tel Aviv Israel 68125

Sponsors and Collaborators

  • Maccabi Healthcare Services, Israel

Investigators

  • Study Director: Gabriel Chodick, PHD, Head,Epidemiology & Database Reseaech Unit, Medical Division, Maccabi H.S

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maccabi Healthcare Services, Israel
ClinicalTrials.gov Identifier:
NCT01759225
Other Study ID Numbers:
  • MACCVREG1
  • cvdregistry
First Posted:
Jan 3, 2013
Last Update Posted:
Jan 3, 2013
Last Verified:
Dec 1, 2012

Study Results

No Results Posted as of Jan 3, 2013